Chief of Myeloma Service
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Dr. Saad Zafar Usmani received his medical education at Allama Iqbal Medical College in Lahore, Pakistan. He completed a residency in internal medicine at Sinai-Grace Hospital/Wayne State University in Detroit, Michigan and a fellowship in hematology and oncology at the University of Connecticut Health Center in Farmington, Connecticut. He was recruited to the Levine Cancer Institute/Atrium Health in 2013 as the inaugural Division Chief of Plasma Cell Disorders and Director of Clinical Research for Hematologic Malignancies where he built an internationally renowned myeloma program. He now serves as the Chief of Myeloma Service at MSKCC since late 2021. Dr. Usmani is board certified in internal medicine, medical oncology, and hematology and a Fellow of the American College of Physicians. He holds membership in several professional societies and leadership roles on national/international committees, including the International Myeloma Working Group, the ALLIANCE Myeloma Committee (Chair), the SWOG Myeloma Committee (former Vice-Chair), the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), the American Society of Transplant & Cellular Therapy (ASTCT), and the National Cancer Institute Myeloma Steering Committee. Dr. Usmani has authored/co-authored more than 240 peer-reviewed research manuscripts and 300 abstracts at national and international meetings. Active in clinical and translational research, Dr. Usmani has research interests focused on plasma cell disorders—particularly high-risk multiple myeloma.
What is the optimal upfront therapy - 3 or 4 drugs?
Wednesday, September 27, 2023
3:30 PM – 3:40 PM EEST